Table 1: P values for multiple assessments of visible injury, yield, and whole grain for preemergence (PRE) and postemergence (POST) applications of saflufenacil.

ExperimentSource of variationPr > F for analyzed parameters
Visible injurya  YieldWhole grain
1st2nd3rd4th

PREYear (Y)<0.0001<0.0001<0.0001<0.0001<0.0001<0.0001
Block (year)<0.00010.0400.0720.9790.7010.771
Clomazone (C)<0.0001<0.0001<0.00010.0070.0250.772
C*Y<0.0001<0.0001<0.00010.0070.6410.0008
Saflufenacil (S)0.001<0.00010.128<0.00010.1510.699
S*Y0.1980.00030.015<0.00010.9120.669
C*S0.4950.1630.4580.1090.4500.971
C*S*Y0.0470.0200.7640.1090.8090.614

POSTYear (Y)<0.0001<0.0001<0.0001<0.0001<0.0001<0.0001
Block (year)0.0160.193<0.00010.01350.0200.0003
Clomazone (C)<0.0001<0.00010.5890.3290.0120.029
C*Y0.0170.0260.5890.3290.0500.029
Saflufenacil (S)<0.0001<0.0001<0.0001<0.00010.2720.7475
S*Y<0.0001<0.0001<0.0001<0.00010.6590.804
C*S<0.0001<0.00010.00080.00370.6340.274
C*S*Y<0.0001<0.00010.00080.00370.9730.956

aRepresents the 1st, 2nd, 3rd, and 4th assessment evaluations for visible injury.